Skip to content

the effectiveness of motivational interviewing with pelvic floor exercises on the sexual function of women with endometriosis

Comparing the effectiveness of motivational interviewing with pelvic floor exercises on the sexual function of women with endometriosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240623062218N1
Enrollment
60
Registered
2024-09-14
Start date
2024-10-06
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis. Endometriosis

Interventions

Intervention 1: The intervention in the motivational interview group is carried out during 6 sessions of 90 minutes and once a week and on the authorized virtual network through the presentation of au

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1. Women with endometriosis according to the diagnosis of the attending physician or recorded in the medical record 2. Having the desire and informed consent to participate in the research 3. Iranian nationality 4. Having the ability to read and write and speak Persian 5. Possibility to participate in training sessions 6. Women who live with their spouses and are the only spouses of their husbands. 7. Ages 15-49 years 8. Having an Android or iOS smart phone

Exclusion criteria

Exclusion criteria: 1. Being pregnant or being treated with assisted reproductive methods 2. Existence of chronic diseases such as diabetes, cardiovascular, etc. 3. Simultaneous participation in similar studies 4. Existence of various types of severe mental disorders (psychosis, schizophrenia, etc.) under drug treatment based on information in the medical record or his statements 5. Existence of stressful events in the past 6 months such as immigration, death of relatives, divorce and does not have financial problems. 6. Use of tobacco, drugs and alcohol according to the patient 7. Presence of uterine prolapse or cystocele or rectocele grade 3 and 8. Suffering from other diseases affecting sexual function such as vaginismus, vestibulodynia, vulval skin diseases, painful bladder syndrome or interstitial cystitis, pregnancy9.Getting gynecological cancers (uterus, ovaries and appendages)

Design outcomes

Primary

MeasureTime frame
Sexual function. Timepoint: Baseline, immediately and two months after the intervention. Method of measurement: Female Sexual Function Index (FSFI).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Fatemeh ZareMobini

Yazd University of Medical Sciences

Fatemehzaremobini@yahoo.com+98 35 3824 1753

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Sep 9, 2026